Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
LH · NYSE · United States · Services-Medical Laboratories
In shortLABCORP HOLDINGS INC. is profitable, generates cash and carries moderate debt, with revenue growing (+7.2% last year).
Financial health
Solid
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 9.9% | 50/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | 6.3% | 45/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | 10.5% | 53/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 6.7% | 44/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.42× | 52/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.65× | 75/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 2.45× | 44/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 6.18× | 45/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 3.39 | 59/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 8.6% | 55/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | 1.38× | 100/100 |
| Years with positive free cash flow (last 5) | 5 of 5 | 100/100 |
Weight in the score: 20%
| Profitable years (last 5) | 5 of 5 | 100/100 |
|---|---|---|
| Years of revenue decline (last 5) | 2 of 5 | 33/100 |
| Revenue growth volatility | 7.7% | 83/100 |
| Operating margin volatility | 6.7% | 48/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 5.6% | 48/100 |
|---|---|---|
| EPS growth, 3-year average | -9.2% | 0/100 |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 13,136 | 11,864 | 12,162 | 13,009 | 13,952 |
| Cost of revenue | 8,144 | 8,155 | 8,797 | 9,385 | 9,939 |
| Gross profit | 4,992 | 3,709 | 3,365 | 3,624 | 4,013 |
| Selling, general & admin | 1,690 | 1,763 | 2,021 | 2,230 | 2,216 |
| Operating income | 3,049 | 1,437 | 726 | 1,087 | 1,385 |
| Interest expense | 212 | 180 | 200 | 208 | 224 |
| Pre-tax income | 2,455 | 1,098 | 504 | 630 | 729 |
| Income tax | 690 | 234 | 189 | 212 | 230 |
| Net income | 2,377 | 1,279 | 418 | 746 | 877 |
| Diluted EPS | $24.39 | $13.97 | $4.77 | $8.84 | $10.46 |
| Diluted shares (millions) | 98 | 92 | 88 | 84 | 84 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 8 reported quarters (10-Q and 10-K filings), in USD millions. The fourth quarter is derived from the annual report.
The last 8 quarters of LABCORP HOLDINGS INC. are included in the Investor plan. Try free for 7 days →
3.39 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
8/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026